Literature DB >> 15216198

Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypass.

Adolph J Koska1, Alexander Romagnoli, William G. Kramer.   

Abstract

The pharmacodynamics of fentanyl citrate were studied in two groups of patients. One group underwent surgery with cardiopulmonary bypass (CPB) and the other group had surgery without CPB; the latter group represented the controls. Apneic periods were considerably longer (2.70 +/- 0.90 hr) for the CPB patients than for the control patients (1.75 +/- 0.75 hr). The total plasma fentanyl concentration at which apnea ceased was not statistically different between the two groups. Minor differences were attributed to the massive dilution of plasma proteins after the adding of priming fluid to the heart-lung machine. This prolongation of apnea is of considerable clinical importance because it means that CPB patients must remain mechanically ventilated for longer periods.

Entities:  

Year:  1981        PMID: 15216198      PMCID: PMC287964     

Source DB:  PubMed          Journal:  Cardiovasc Dis        ISSN: 0093-3546


  10 in total

1.  High dose fentanyl anesthesia for coronary artery surgery: plasma fentanyl concentrations and influence of nitrous oxide on cardiovascular responses.

Authors:  J K Lunn; T H Stanley; J Eisele; L Webster; A Woodward
Journal:  Anesth Analg       Date:  1979 Sep-Oct       Impact factor: 5.108

2.  Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.

Authors:  J G Bovill; P S Sebel
Journal:  Br J Anaesth       Date:  1980-08       Impact factor: 9.166

3.  The magnitude and duration of respiratory depression due to fentanyl and meperidine in man.

Authors:  J J Downes; R A Kemp; C J Lambertsen
Journal:  J Pharmacol Exp Ther       Date:  1967-12       Impact factor: 4.030

4.  Hemodynamic and ventilatory responses to fentanyl, fentanyl-droperidol, and nitrous oxide in patients with acquired valvular heart disease.

Authors:  R K Stoelting; P S Gibbs; C W Creasser; C Peterson
Journal:  Anesthesiology       Date:  1975-03       Impact factor: 7.892

5.  The magnitude and duration of respiratory depression produced by fentanyl and fentanyl plus droperidol in man.

Authors:  M H Harper; R F Hickey; T H Cromwell; S Linwood
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

6.  Pharmacokinetics of fentanyl as determined by radioimmunoassay.

Authors:  R Schleimer; E Benjamini; J Eisele; G Henderson
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

7.  Effect of cardiopulmonary bypass on fentanyl distribution and elimination.

Authors:  A J Koska; A Romagnoli; W G Kramer
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

8.  Potassium replacement during cardiopulmonary bypass.

Authors:  R Babka; R Pifarré
Journal:  J Thorac Cardiovasc Surg       Date:  1977-02       Impact factor: 5.209

9.  Cephalothin kinetics: before, during, and after cardiopulmonary bypass surgery.

Authors:  K W Miller; K K Chan; H G McCoy; R P Fischer; W G Lindsay; D E Zaske
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

10.  Intravenous fentanyl kinetics.

Authors:  D A McClain; C C Hug
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

  10 in total
  2 in total

1.  Effect of surgery and cardiopulmonary bypass on indocyanine green pharmacokinetics.

Authors:  W G Kramer; A Romagnoli
Journal:  Tex Heart Inst J       Date:  1986-03

2.  Papaverine disposition in cardiac surgery patients and the effect of cardiopulmonary bypass.

Authors:  W G Kramer; A Romagnoli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.